120 related articles for article (PubMed ID: 12536013)
1. Effects of tGLP-1 on feeding behaviour and neurohypophysial function under chronic osmotic stimulation.
Bojanowska E; Stempniak B
Physiol Behav; 2003 Jan; 78(1):73-9. PubMed ID: 12536013
[TBL] [Abstract][Full Text] [Related]
2. Effects of glucagon-like peptide-1 (7-36) amide on neurohypophysial hormone secretion induced by acute hyperosmotic challenge.
Bojanowska E; Stempniak B
Neuropeptides; 2003 Feb; 37(1):45-50. PubMed ID: 12637035
[TBL] [Abstract][Full Text] [Related]
3. Effects of glucagon-like peptide-1(7-36) amide on neurohypophysial and cardiovascular functions under hypo- or normotensive hypovolaemia in the rat.
Bojanowska E; Stempniak B
J Endocrinol; 2002 Feb; 172(2):303-10. PubMed ID: 11834448
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms involved in glucagon-like peptide-1 (7-36) amide action on the rat hypothalamo-neurohypophysial system.
Bojanowska E; Stempniak B
Neuroendocrinology; 2003 Feb; 77(2):119-24. PubMed ID: 12624533
[TBL] [Abstract][Full Text] [Related]
5. tGLP-1 and release of vasopressin and oxytocin from the isolated rat hypothalamo-neurohypophysial system: effects of a tGLP-1 receptor agonist and antagonist.
Bojanowska E; Stempniak B
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 2):781-93. PubMed ID: 11785773
[TBL] [Abstract][Full Text] [Related]
6. Thyrotropin-releasing hormone (TRH) modifies oxytocin release from the hypothalamo-neurohypophysial system in salt-loaded rats.
Ciosek J; Stempniak B
J Physiol Pharmacol; 1995 Jun; 46(2):169-77. PubMed ID: 7670125
[TBL] [Abstract][Full Text] [Related]
7. tGLP-1 action on the isolated hypothalamo-neurohypophysial system under glutamate receptor blockade.
Bojanowska E; Stempniak B
Brain Res Bull; 2002 Sep; 58(6):555-9. PubMed ID: 12372558
[TBL] [Abstract][Full Text] [Related]
8. Galanin influences vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of salt loaded rats.
Cisowska-Maciejewska A; Ciosek J
J Physiol Pharmacol; 2005 Dec; 56(4):673-88. PubMed ID: 16391423
[TBL] [Abstract][Full Text] [Related]
9. Reduced depletion of neurohypophysial hormone stores by vasopressin administration in rats drinking 2% NaCl.
Bakker HR; Dyball RE
Neuroendocrinology; 1975; 18(1):92-103. PubMed ID: 1143633
[TBL] [Abstract][Full Text] [Related]
10. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.
Larsen PJ; Fledelius C; Knudsen LB; Tang-Christensen M
Diabetes; 2001 Nov; 50(11):2530-9. PubMed ID: 11679431
[TBL] [Abstract][Full Text] [Related]
11. Oestrogen receptor-beta and neurohypophysial hormones: functional interaction and neuroanatomical localisation.
Forsling ML; Kalló I; Hartley DE; Heinze L; Ladek R; Coen CW; File SE
Pharmacol Biochem Behav; 2003 Dec; 76(3-4):535-42. PubMed ID: 14643853
[TBL] [Abstract][Full Text] [Related]
12. A study on the release mechanism of vasopressin and oxytocin.
Hashimoto H; Noto T; Nakajima T
Neuropeptides; 1988; 12(4):199-206. PubMed ID: 3237319
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin affects water intake as well as neurohypophysial storage of vasopressin and oxytocin in the rat.
Guzek JW; Morawska J
Exp Clin Endocrinol; 1986 Dec; 88(2):200-6. PubMed ID: 3556409
[TBL] [Abstract][Full Text] [Related]
14. Possible contribution of dopaminergic receptors in the anteroventral third ventricular region to hyperosmolality-induced vasopressin secretion in conscious rats.
Yamaguchi K; Hama H; Watanabe K
Eur J Endocrinol; 1996 Feb; 134(2):243-50. PubMed ID: 8630527
[TBL] [Abstract][Full Text] [Related]
15. Vasopressin and oxytocin release as influenced by thyrotropin-releasing hormone in euhydrated and dehydrated rats.
Ciosek J
J Physiol Pharmacol; 2002 Sep; 53(3):423-37. PubMed ID: 12369739
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic factor inhibits the stimulated in-vivo and in-vitro release of vasopressin and oxytocin in the rat.
Poole CJ; Carter DA; Vallejo M; Lightman SL
J Endocrinol; 1987 Jan; 112(1):97-102. PubMed ID: 2950195
[TBL] [Abstract][Full Text] [Related]
17. Effects of glucagon and glucagon-like peptide-1-(7-36) amide on C cells from rat thyroid and medullary thyroid carcinoma CA-77 cell line.
Crespel A; De Boisvilliers F; Gros L; Kervran A
Endocrinology; 1996 Sep; 137(9):3674-80. PubMed ID: 8756532
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of intracerebroventricular glucagon-like peptide-1 on feeding and energy expenditure regulation.
Hwa JJ; Ghibaudi L; Williams P; Witten MB; Tedesco R; Strader CD
Peptides; 1998; 19(5):869-75. PubMed ID: 9663452
[TBL] [Abstract][Full Text] [Related]
19. Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1.
Nakabayashi H; Nishizawa M; Nakagawa A; Takeda R; Niijima A
Am J Physiol; 1996 Nov; 271(5 Pt 1):E808-13. PubMed ID: 8944665
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 (7-36) amide administered into the third cerebroventricle inhibits water intake in rats.
Wang T; Edwards GL; Baile CA
Proc Soc Exp Biol Med; 1998 Oct; 219(1):85-91. PubMed ID: 9751227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
